Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies
Niyati Jakharia, Dianna S. Howard, David J. Riedel
Current treatment options in infectious diseases/Current treatment options in infectious disease (2021) Vol. 13, Iss. 3, pp. 123-140
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir
Genovefa A. Papanicolaou, Robin K. Avery, Catherine Cordonnier, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 3, pp. 562-572
Open Access | Times Cited: 24
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)
Federica Galaverna, Francesco Baccelli, Daniele Zama, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 4, pp. 505-512
Closed Access | Times Cited: 11
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system
Qiang Gong, Linlin Zhang, Hui Wu, et al.
International Journal of Clinical Pharmacy (2025)
Closed Access | Times Cited: 1
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
Camille N. Kotton, Julián Torre‐Cisneros, José María Aguado, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 32
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT
Simone Cesaro, Per Ljungman, Gloria Tridello, et al.
Bone Marrow Transplantation (2022) Vol. 58, Iss. 2, pp. 203-208
Open Access | Times Cited: 27
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients
Katharina F. Körholz, Miriam A. Füller, Marc Tim Hennies, et al.
Pediatric Drugs (2022) Vol. 25, Iss. 2, pp. 225-232
Open Access | Times Cited: 27
Letermovir as Cytomegalovirus Prophylaxis in a Pediatric Cohort: A Retrospective Analysis
Alexis Kuhn, Jenna Puttkammer, Theresa Madigan, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 62.e1-62.e4
Open Access | Times Cited: 24
CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
Kirsten Alexandra Eberhardt, Verena Jung, Elena Knops, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 6, pp. 639-646
Open Access | Times Cited: 15
Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation
Teaghan T. Chen, Alexandria P. David, Erin K. Barthelmess, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 11
Open Access | Times Cited: 14
Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review, Meta‐Analysis, and Meta‐Regression
Abdullah Yousef Aldalati, Ayham Mohammad Hussein, Elsayed Balbaa, et al.
Transplant Infectious Disease (2025)
Closed Access
M1 enrichment facilitates virus detection in patients with allogeneic hematopoietic stemcell transplantation
Hao Zheng, Sai Li, Zeyin Liang, et al.
Medicine (2025) Vol. 104, Iss. 9, pp. e41683-e41683
Open Access
Immune reconstitution of human cytomegalovirus-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation and their predictive role in reactivation
Yuanqi Zhao, Sisi Zhen, Jiali Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Protein-S-nitrosylation of human cytomegalovirus pp65 reduces its ability to undermine cGAS
Justin B. Cox, Masatoshi Nukui, Eain A. Murphy
Journal of Virology (2025)
Open Access
Discovery and Development of Brincidofovir

(2025), pp. 447-500
Closed Access
Comparison of Letermovir Versus Ganciclovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant Recipients
Catherine E. Martin, Mira A. Kohorst, Asmaa Ferdjallah, et al.
Pediatric Blood & Cancer (2025)
Closed Access
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance
Waqas Ahmed, Louise Longworth, Yemi Oluboyede, et al.
Health and Quality of Life Outcomes (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV
Markus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 2
Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis
Mohammad Reza Taherian, Pouya Azarbar, Maryam Barkhordar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 2
Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation
Tang‐Her Jaing, Yi-Lun Wang, Chia-Chi Chiu
Viruses (2024) Vol. 16, Iss. 8, pp. 1268-1268
Open Access | Times Cited: 2
A Systematic Literature Review to Identify Diagnostic Gaps in Managing Immunocompromised Patients With Cancer and Suspected Infection
Joshua A. Hill, Sarah Y. Park, Kiran Gajurel, et al.
Open Forum Infectious Diseases (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
‘Getting Better’—Is It a Feasible Strategy of Broad Pan-Antiherpesviral Drug Targeting by Using the Nuclear Egress-Directed Mechanism?
Julia Tillmanns, Jintawee Kicuntod, Josephine Lösing, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2823-2823
Open Access | Times Cited: 1
Cytomegalovirus infection risk with alemtuzumab therapy in hematological malignancies: a retrospective cohort study in the non-transplant setting
Joel George, Lee Mozessohn, Philip W. Lam
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1716-1723
Closed Access | Times Cited: 1
Cytomegalovirus Infections in Hematopoietic Stem Cell Transplant: Moving Beyond Molecular Diagnostics to Immunodiagnostics
Chhavi Gupta, Netto George Mundan, Shukla Das, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2523-2523
Open Access | Times Cited: 1
Pneumonia in Transplant Recipients: A Comprehensive Review of Diagnosis and Management
Ramakanth Pata, J. Kristeva, Bhanu Kosuru
Cureus (2024)
Open Access | Times Cited: 1
CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
Melissa Panesso, María Luz Uria Oficialdegui, Berta Renedo, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top